Andexanet Alfa Versus Prothrombin Complex Concentrates/Blood Products as Apixaban/Rivaroxaban Reversal Agents: A Survey Among Pediatric Hematologists

Direct oral factor Xa inhibitors (DXIs) are approved for use in adult patients with non-valvular heart disease for stroke prevention, and the treatment/prevention of venous thromboembolism (VTE). Recent pediatric clinical trials have demonstrated safety and efficacy of direct oral anticoagulants (DO...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez, Vilmarie, Stanek, Joseph, Kerlin, Bryce A., Dunn, Amy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Manuscript
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921759/
https://www.ncbi.nlm.nih.gov/pubmed/35275498
http://dx.doi.org/10.1177/10760296221078842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921759/
https://www.ncbi.nlm.nih.gov/pubmed/35275498
http://dx.doi.org/10.1177/10760296221078842

Ejemplares similares